Integrated genomic and transcriptomic analysis to predict FOLFIRINOX response in metastatic pancreatic ductal adenocarcinoma

被引：0
|
作者：
Lansbergen, Marjolein Francisca
Dings, Mark Pui Gien
Koster, Jan
Wilmink, Johanna
Van Laarhoven, Hanneke W. M.
Bijlsma, Maarten F.
机构：
[1] Amsterdam UMC, Amsterdam, Netherlands
[2] Amsterdam UMC, Ctr Expt Mol Med, Amsterdam, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4153
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Integrated in vivo dissection of metastatic phenotypes and molecular programs in pancreatic ductal adenocarcinoma
    Karmakar, Saswati
    Lyulina, Anastasia
    Xiong, Xiaochen
    Tang, Yuning J.
    Lopez, Steven
    Hughes, Nicolas William
    Attardi, Laura
    Petrov, Dmitri A.
    Winslow, Monte M.
    CANCER RESEARCH, 2024, 84 (02)
  • [32] Comparative Analysis of Metabolic Response to Clinical Outcome in Metastatic Pancreatic Adenocarcinoma following Modified Dose Folfirinox.
    Boustani, A.
    Patel, V.
    Cong, X.
    Doddamane, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S296 - S297
  • [33] FOLFIRINOX for Pancreatic Ductal Adenocarcinoma (vol 25, pg 726, 2019)
    Alakus, Hakan
    Korenkov, Michael
    Kuetting, Fabian
    Bruns, Christiane
    ONKOLOGE, 2019, 25 (08): : 728 - 728
  • [34] FOLFIRINOX beim duktalen Adenokarzinom des PankreasFOLFIRINOX for pancreatic ductal adenocarcinoma
    Hakan Alakus
    Michael Korenkov
    Fabian Kütting
    Christiane Bruns
    Der Onkologe, 2019, 25 (8): : 726 - 727
  • [35] Transcriptomic characterisation of the diabetogenic pancreatic ductal adenocarcinoma phenotype
    Stott, Martyn
    Hasoon, Megan
    Oldfield, Lucy
    Soul, Jamie
    Halloran, Christopher
    Costello, Eithne
    BRITISH JOURNAL OF SURGERY, 2024, 111
  • [36] Long-Term Survival of FOLFIRINOX plus toripalimab in a Patient with Metastatic Pancreatic Ductal Adenocarcinoma: A Case Report
    Jiang, Ting
    Gao, Chen
    Luo, Yiyang
    Ye, Zixiang
    Wang, Binbin
    ONCOTARGETS AND THERAPY, 2022, 15 : 883 - 890
  • [37] Integrated microRNA-mRNA analysis of pancreatic ductal adenocarcinoma
    Liu, P. F.
    Jiang, W. H.
    Han, Y. T.
    He, L. F.
    Zhang, H. L.
    Ren, H.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (03): : 10288 - 10297
  • [38] Integrated stress response is critical for gemcitabine resistance in pancreatic ductal adenocarcinoma
    Palam, L. R.
    Gore, J.
    Craven, K. E.
    Wilson, J. L.
    Korc, M.
    CELL DEATH & DISEASE, 2015, 6 : e1913 - e1913
  • [39] Integrated stress response is critical for gemcitabine resistance in pancreatic ductal adenocarcinoma
    L R Palam
    J Gore
    K E Craven
    J L Wilson
    M Korc
    Cell Death & Disease, 2015, 6 : e1913 - e1913
  • [40] Genome Transcriptomic Analysis to Elucidate the Effects of Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma
    Okawa, Yuki
    Ebata, Nobutaka
    Sasagawa, Shota
    Nakamura, Toru
    Hirano, Satoshi
    Nakagawa, Hidewaki
    CANCER SCIENCE, 2022, 113 : 432 - 432
12345